impaginato piccolo - Società Italiana di Parassitologia (SoIPa)

42
References
Ades AE, Gilbert R, Thiebaut R, Welton NJ, Caldwell DM, Leroy
V for the EUROTOXO Group (2005) Antenatal screening programme
for congenital toxoplasmosis: outline of an analysis of
effectiveness, cost- effectiveness, and the value of further
research. http://eurotoxo.isped.u-bordeaux2.fr/.
Aramini JJ, Stephen C, Dubey JP, Engelstoft C, Schwantje H,
Ribble CS. (1999). Potential contamination of drinking water
with Toxoplasma gondii oocysts. Epidemiol Infect. 122: 305-15.
Bénard A, Petersen E, Salamon R, Chêne G, Gilbert R, Salmi LR;
European Toxo Prevention Study Group (EUROTOXO) (2008).
Survey of European programmes for the epidemiological surveillance
of congenital toxoplasmosis. Euro Surveill. 13:
18834.
Binquet C, Wallon M, Quantin C, Kodjikian L, Garweg J, Fleury J,
Peyron F, Abrahamowicz M. (2003). Prognostic factors for the
long-term development of ocular lesions in 327 children with
congenital toxoplasmosis. Epidemiol Infect. 131: 1157-68.
Breugelmans M, Naessens A, Foulon W. (2004). Prevention of
toxoplasmosis during pregnancy—an epidemiologic survey
over 22 consecutive years. J Perinat Med. 32: 211-4.
Buffolano W, Beghetto E, Del Pezzo M, Spadoni A, Di Cristina M,
Petersen E, Gargano N. (2005). Use of recombinant antigens for
early postnatal diagnosis of congenital toxoplasmosis. J Clin
Microbiol. 43: 5916-24.
Buffolano W (2003). Failure to implement a preventive strategy
against congenital toxoplasmosis in Italy. Arch Pediatr.10 Suppl
1:21-2.
Buffolano W, Gilbert RE, Holland FJ, Fratta D, Palumbo F, Ades
AE. (1996). Risk factors for recent toxoplasma infection in pregnant
women in Naples. Epidemiol Infect. 116: 347-51.
Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum
PA, Foulon W, Semprini AE, Dunn DT. (2000). Sources of toxoplasma
infection in pregnant women: European multicentre
case-control study. European Research Network on Congenital
Toxoplasmosis. BMJ. 321:142-7.
de Moura L, Bahia-Oliveira LM, Wada MY, Jones JL, Tuboi SH,
Carmo EH, Ramalho WM, Camargo NJ, Trevisan R, Graça RM,
da Silva AJ, Moura I, Dubey JP, Garrett DO. (2006).
Waterborne toxoplasmosis, Brazil, from field to gene. Emerg
Infect Dis. 12: 326-9.
Forsgren M, Gille E, Ljungström I, Nokes DJ. (1991). Toxoplasma
gondii antibodies in pregnant women in Stockholm in 1969,
1979, and 1987. Lancet 337: 1413-4.
Foulon W, Naessens A, Ho-Yen D. (2000). Prevention of congenital
toxoplasmosis. J Perinat Med. 28: 337-45.
Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M,
Pinon JM, Jenum PA, Hedman K, Naessens A. (1999).
Treatment of toxoplasmosis during pregnancy: a multicenter
study of impact on fetal transmission and children’s sequelae at
age 1 year. Am J Obstet Gynecol. 180: 410-5.
Freeman K, Oakley L, Pollak A, Buffolano W, Petersen E, Semprini
AE, Salt A, Gilbert R; European Multicentre Study on Congenital
Toxoplasmosis. (2005). Association between congenital toxoplasmosis
and preterm birth, low birthweight and small for gestational
age birth. BJOG 112: 31-7.
Freeman K, Salt A, Prusa A, Malm G, Ferret N, Buffolano W,
Schmidt D, Tan HK, Gilbert RE; European Multicentre Study on
Congenital Toxoplasmosis. (2005). Association between con-
W. Buffolano - Toxoprev
genital toxoplasmosis and parent-reported developmental outcomes,
concerns, and impairments, in 3 year old children. BMC
Pediatr. 5: 23- 32.
Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LMG, Tan HK,
Wallon M, Buffolano W, Stanford MR, Petersen E for the
European Multicentre Study on Congenital Toxoplasmosis
(EMSCOT) (2008) Ocular sequelae of congenital toxoplasmosis
in Brazil compared with Europe. PLoS Neglected Tropical
Diseases, in press.
Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M, Petersen E;
European Multicentre Study on Congenital Toxoplasmosis.
(2007). Screening for congenital toxoplasmosis: accuracy of
immunoglobulin M and immunoglobulin A tests after birth. J
Med Screen. 14: 8-13.
Gilbert R, Gras L; European Multicentre Study on Congenital
Toxoplasmosis. (2003). Effect of timing and type of treatment on
the risk of mother to child transmission of Toxoplasma gondii.
BJOG. 110: 112-20.
Gilbert R, Dunn D, Wallon M, Hayde M, Prusa A, Lebech M,
Kortbeek T, Peyron F, Pollak A, Petersen E. (2001). Ecological
comparison of the risks of mother-to-child transmission and
clinical manifestations of congenital toxoplasmosis according to
prenatal treatment protocol. Epidemiol Infect. 127: 113-20.
Gilbert RE. (2000) Toxoplasmosis. Newell ML, McIntyre J, eds.
Congenital and Perinatal Infections. 1st ed., Cambridge:
Cambridge University Press: 305- 20.
Gollub EL, Leroy V, Gilbert R, Chêne G, Wallon M; European
Toxoprevention Study Group (EUROTOXO) (2008).
Effectiveness of health education on Toxoplasma-related
knowledge, behaviour, and risk of seroconversion in pregnancy.
Eur J Obstet Gynecol Reproduc.136:137-45.
Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde
M, Petersen E, Gilbert R; European Multicenter Study on
Congenital Toxoplasmosis. (2005). Association between prenatal
treatment and clinical manifestations of congenital toxoplasmosis
in infancy: a cohort study in 13 European centres. Acta
Paediatr. 94: 1721-31.
Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R,
Stechenberg B, Abroms I, Pasternack MS, Hoff R, Eaton RB, et
al. (1994). Neonatal serologic screening and early treatment for
congenital Toxoplasma gondii infection. The New England
Regional Toxoplasma Working Group. N Engl J Med. 330:
1858-63.
Hill DE, Benedetto SM, Coss C, McCrary JL, Fournet VM, Dubey
JP. (2006). Effects of time and temperature on the viability of
Toxoplasma gondii tissue cysts in enhanced pork loin. J Food
Prot. 69: 1961-5.
Hintz SR, Slovis T, Bulas D, Van Meurs KP, Perritt R, Stevenson
DK, Poole WK, Das A, Higgins RD; NICHD Neonatal Research
Network. (2007). Interobserver reliability and accuracy of cranial
ultrasound scanning interpretation in premature infants. J
Pediatr. 150: 592-6.
Jamieson SE, de Roubaix LA, Kuan Tan H, Cortina-Borja M, Mui
E, Cordell HJ, Mack D, Kirisitsand M, Miller EN, Peacock C,
Hargrave A, Boyer K, Bardo D, Bessieres MH, Buffolano W,
Ferret N, Franck J, Heydemann P, Kieffer F, Meier P, Mets M,
Nowakowska DE, Patel D, Paul M, Peyron F, Stray-Pedersen
B, Remington J, Swisher CN, Thulliez P, Wallon M, Petersen
E, McLeod R, Gilbert RE, and Blackwell JM. (2008). COL2A1
and ABCA4 are epigenetically modified and associated with